down arrow

China Resources Double-Crane Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000Q94
CNY
18.87
0.12 (0.64%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
China Resources Double-Crane Pharmaceutical Co., Ltd.
Why is China Resources Double-Crane Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 4.96% and Operating profit at 7.75% over the last 5 years
2
With a fall in Net Sales of -13.92%, the company declared Very Negative results in Mar 25
  • The company has declared negative results for the last 2 consecutive quarters
  • The company has declared negative results in Dec 24 after 3 consecutive negative quarters
  • DEBTORS TURNOVER RATIO(HY) Lowest at 3.86%
  • INTEREST(Q) Highest at CNY 8.61 MM
3
With ROE of 14.83%, it has a very attractive valuation with a 1.73 Price to Book Value
  • Over the past year, while the stock has generated a return of -10.44%, its profits have fallen by -2.9%
  • At the current price, the company has a high dividend yield of 2.6
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -10.44% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to China Resources Double-Crane Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is China Resources Double-Crane Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
China Resources Double-Crane Pharmaceutical Co., Ltd.
-10.44%
-0.57
20.97%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
4.96%
EBIT Growth (5y)
7.75%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.93
Tax Ratio
12.36%
Dividend Payout Ratio
29.74%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.98%
ROE (avg)
12.30%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.73
EV to EBIT
11.24
EV to EBITDA
7.56
EV to Capital Employed
1.83
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
2.57%
ROCE (Latest)
16.31%
ROE (Latest)
14.83%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
RAW MATERIAL COST(Y)

Fallen by -3.76% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 3.52%

-13What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 3.86%

INTEREST(Q)

Highest at CNY 8.61 MM

Here's what is working for China Resources Double-Crane Pharmaceutical Co., Ltd.
Inventory Turnover Ratio
Highest at 3.52%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -3.76% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for China Resources Double-Crane Pharmaceutical Co., Ltd.
Interest
At CNY 8.61 MM has Grown at 51.55%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest
Highest at CNY 8.61 MM
in the last five periods and Increased by 51.55% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio
Lowest at 3.86%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."